Annual ROA
-26.44%
+19.65%+42.63%
31 December 2023
Summary:
EyePoint Pharmaceuticals annual return on assets is currently -26.44%, with the most recent change of +19.65% (+42.63%) on 31 December 2023. During the last 3 years, it has risen by +28.69% (+52.04%). EYPT annual ROA is now -214.66% below its all-time high of 23.06%, reached on 30 June 2015.EYPT ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-35.24%
-2.95%-9.14%
30 September 2024
Summary:
EyePoint Pharmaceuticals quarterly return on assets is currently -35.24%, with the most recent change of -2.95% (-9.14%) on 30 September 2024. Over the past year, it has increased by +20.95% (+37.28%). EYPT quarterly ROA is now -187.95% below its all-time high of 40.07%, reached on 30 September 2014.EYPT Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +42.6% | +37.3% |
| 3 y3 years | +52.0% | +9.1% |
| 5 y5 years | +55.7% | +63.4% |
EYPT ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +52.0% | -9.4% | +37.3% |
| 5 y | 5 years | at high | +64.8% | -9.4% | +63.4% |
| alltime | all time | -214.7% | +77.5% | -187.9% | +79.1% |
EyePoint Pharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -35.24%(+9.1%) |
| June 2024 | - | -32.29%(-3.9%) |
| Mar 2024 | - | -33.59%(-2.7%) |
| Dec 2023 | -26.44%(-42.6%) | -34.51%(-38.6%) |
| Sept 2023 | - | -56.19%(+2.3%) |
| June 2023 | - | -54.93%(+10.8%) |
| Mar 2023 | - | -49.56%(+10.7%) |
| Dec 2022 | -46.09%(+40.1%) | -44.76%(+29.3%) |
| Sept 2022 | - | -34.61%(-1.5%) |
| June 2022 | - | -35.15%(+9.2%) |
| Mar 2022 | - | -32.20%(-1.9%) |
| Dec 2021 | -32.90%(-40.3%) | -32.84%(-15.3%) |
| Sept 2021 | - | -38.75%(+12.6%) |
| June 2021 | - | -34.40%(-21.8%) |
| Mar 2021 | - | -44.01%(-24.1%) |
| Dec 2020 | -55.13%(-26.6%) | -57.98%(+8.9%) |
| Sept 2020 | - | -53.24%(-19.7%) |
| June 2020 | - | -66.33%(+6.0%) |
| Mar 2020 | - | -62.55%(-8.8%) |
| Dec 2019 | -75.15%(+25.9%) | -68.58%(-28.8%) |
| Sept 2019 | - | -96.31%(-24.8%) |
| June 2019 | - | -128.03%(-16.2%) |
| Mar 2019 | - | -152.85%(-9.3%) |
| Dec 2018 | -59.69%(-49.3%) | - |
| Sept 2018 | - | -168.58%(+6.5%) |
| June 2018 | -117.70%(+60.1%) | -158.22%(+44.9%) |
| Mar 2018 | - | -109.16%(-20.9%) |
| Dec 2017 | - | -137.93%(+50.1%) |
| Sept 2017 | - | -91.87%(+11.8%) |
| June 2017 | -73.50%(+9.1%) | -82.17%(+13.9%) |
| Mar 2017 | - | -72.16%(+5.5%) |
| Dec 2016 | - | -68.38%(-17.1%) |
| Sept 2016 | - | -82.48%(+16.0%) |
| June 2016 | -67.35%(-392.1%) | -71.08%(+9.0%) |
| Mar 2016 | - | -65.23%(+2.8%) |
| Dec 2015 | - | -63.46%(+18.9%) |
| Sept 2015 | - | -53.36%(-393.7%) |
| June 2015 | 23.06%(-133.6%) | 18.17%(-18.7%) |
| Mar 2015 | - | 22.36%(-33.6%) |
| Dec 2014 | - | 33.69%(-15.9%) |
| Sept 2014 | - | 40.07%(-165.1%) |
| June 2014 | -68.63% | -61.55%(-3.1%) |
| Mar 2014 | - | -63.53%(-8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | - | -69.73%(+9.6%) |
| Sept 2013 | - | -63.60%(+7.3%) |
| June 2013 | -64.59%(-12.0%) | -59.29%(+24.1%) |
| Mar 2013 | - | -47.76%(+6.6%) |
| Dec 2012 | - | -44.82%(-51.6%) |
| Sept 2012 | - | -92.54%(+18.2%) |
| June 2012 | -73.36%(+283.1%) | -78.28%(+27.5%) |
| Mar 2012 | - | -61.40%(+9.6%) |
| Dec 2011 | - | -56.03%(+214.1%) |
| Sept 2011 | - | -17.84%(-7.9%) |
| June 2011 | -19.15%(-187.6%) | -19.38%(-270.0%) |
| Mar 2011 | - | 11.40%(-8.5%) |
| Dec 2010 | - | 12.46%(-37.6%) |
| Sept 2010 | - | 19.98%(-19.1%) |
| June 2010 | 21.85%(-503.9%) | 24.70%(-273.6%) |
| Mar 2010 | - | -14.23%(+83.9%) |
| Dec 2009 | - | -7.74%(-17.1%) |
| Sept 2009 | - | -9.34%(+60.5%) |
| June 2009 | -5.41%(-94.3%) | -5.82%(-94.8%) |
| Mar 2009 | - | -111.33%(+15.6%) |
| Dec 2008 | - | -96.28%(+13.2%) |
| Sept 2008 | - | -85.08%(+12.0%) |
| June 2008 | -95.61%(+27.9%) | -75.95%(+229.1%) |
| Mar 2008 | - | -23.08%(-14.8%) |
| Dec 2007 | - | -27.10%(-14.8%) |
| Sept 2007 | - | -31.80%(-926.0%) |
| June 2007 | -74.76%(+337.2%) | 3.85%(-63.1%) |
| Mar 2007 | - | 10.43%(-17.8%) |
| Dec 2006 | - | 12.69%(+0.2%) |
| Sept 2006 | - | 12.66%(-203.3%) |
| June 2006 | -17.10%(-34.4%) | -12.25%(-60.4%) |
| Mar 2006 | - | -30.95%(+14.8%) |
| Dec 2005 | - | -26.97%(+18.1%) |
| Sept 2005 | - | -22.83%(+26.3%) |
| June 2005 | -26.08%(+67.5%) | -18.07%(-42.7%) |
| Mar 2005 | - | -31.55%(+32.0%) |
| Dec 2004 | - | -23.91%(+48.2%) |
| Sept 2004 | - | -16.13%(+83.1%) |
| June 2004 | -15.57%(-59.6%) | -8.81%(-83.8%) |
| Mar 2004 | - | -54.47%(+12.2%) |
| Dec 2003 | - | -48.56%(+15.0%) |
| Sept 2003 | - | -42.23%(+14.0%) |
| June 2003 | -38.54%(+318.5%) | -37.03% |
| June 2001 | -9.21% | - |
FAQ
- What is EyePoint Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual ROA year-on-year change?
- What is EyePoint Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly ROA year-on-year change?
What is EyePoint Pharmaceuticals annual return on assets?
The current annual ROA of EYPT is -26.44%
What is the all time high annual ROA for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual return on assets is 23.06%
What is EyePoint Pharmaceuticals annual ROA year-on-year change?
Over the past year, EYPT annual return on assets has changed by +19.65% (+42.63%)
What is EyePoint Pharmaceuticals quarterly return on assets?
The current quarterly ROA of EYPT is -35.24%
What is the all time high quarterly ROA for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly return on assets is 40.07%
What is EyePoint Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, EYPT quarterly return on assets has changed by +20.95% (+37.28%)